Back to search

Netherlands· NL-e42f9f8c639b

Bisoprololfumaraat/Hydrochloorthiazide CF 10/25 mg, filmomhulde tabletten

A bisoprolol und thiazide product containing bisoprololfumaraat + hydrochloorthiazide, registered in Netherlands by Centrafarm B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC C07BB07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBisoprololfumaraat/Hydrochloorthiazid…ATCC07BB07REGISTER NO.NL-e42f9f8c639bPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Bisoprolol und thiazide is registered in 8 of 19 countries.

Countries holding a registration under ATC C07BB07 (bisoprolol und thiazide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Bisoprolol und thiazide · ATC C07BB07

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Italyprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BISOPROLOLFUMARAAT + HYDROCHLOORTHIAZIDE
Manufacturer
Centrafarm B.V.
Country
Netherlands (NL)
ATC code
C07BB07
ATC class
Bisoprolol und Thiazide
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    29881

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

18 interactions on record for bisoprolol und thiazide.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bisoprolol und thiazide · interactions on record

18 records

18 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e4262cd0-2b16-4938-9227-20f12e39bc37
GET /v1/drugs/e4262cd0-2b16-4938-9227-20f12e39bc37?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h29881_smpc.pdf",
  "strength": null,
  "atc_label": "Bisoprolol And Thiazides",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg29881",
  "excipients": [
    "CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "DIMETICON (E 900)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "MACROGOL",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "BISOPROLOLFUMARAAT",
    "HYDROCHLOORTHIAZIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h29881.pdf",
  "authorised_at": "2005/03/08",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "29881",
  "additional_monitoring": "N"
}

See everything about bisoprolol und thiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.